When patients don’t feel heard by their doctors, there’s an erosion of trust that can lead to serious health consequences—even if clinicians have their patients’ best interests in mind.
Children as young as 4 eat more when bored, study shows
A new study carried out at Aston University has shown that children as young as 4 years old eat 79% more calories when they are bored, compared to when they are in a neutral mood.
Magistrate warns Munir for absconding court
By LUCY PHIRI
LUSAKA magistrate Davies Chibwili has again warned Independent Member of Parliament for Lumezi Constituency, Munir Zulu to attend court in a matter is facing three counts of defamation.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
Researchers develop new resource to aid in cancer surveillance at US cancer centers
With the creation of Cancer InFocus, the University of Kentucky Markey Cancer Center’s Community Impact Office introduced a new tool monitoring the geographic burden of cancer. This resource—launched in 2022—combines powerful data collection software with an interactive online application to accelerate gaining insight from data in the fight against America’s second leading cause of death.
Q&A: Hypertension expert on optimizing blood pressure
High blood pressure, or hypertension, is a common condition affecting nearly half of U.S. adults. According to the Centers for Disease Control and Prevention (CDC), 48% of Americans have high blood pressure—defined as a systolic blood pressure greater than 130 mmHg or a diastolic blood pressure greater than 80 mmHg. A major risk factor for heart disease and other serious health problems, high blood pressure is more common in adults aged 45 and older and disproportionately affects non-white Americans.
Study associates reduced activity of a key enzyme with microcephaly in Zika-infected offspring
Mice that were infected with Zika virus during pregnancy and developed microcephaly displayed less activity of Ndel1, an enzyme that plays a key role in neuron proliferation, differentiation and migration during embryo development, according to an article published in the Journal of Neurochemistry.
Epigenetically acting drugs could support cancer immunotherapy
Epigenetically active drugs enable the cell to read parts oft he genome that were previously blocked and inaccessible. This leads to the formation of new mRNA transcripts and also new proteins, as scientists from the German Cancer Research Center and the University Hospital Tübingen have now described in research published in Nature Communications. These “therapy-induced epitopes” could help the immune system recognize cancer cells.
Q&A: Building a future for testing medical products using non-animal models
For a long time, we’ve relied on animal testing to advance human health. It’s been considered necessary to develop new and effective medical treatments that save human lives. But what if we could reduce or even eliminate the need for animal testing altogether? What if we could turn to innovative, ethical alternatives that are not only more effective but also more humane?
Vedanta to take KCM liabilities – Kabuswe
By NATION REPORTER
VEDANTA Resources has been asked to take up all the current liabilities that Konkola Copper Mine (KCM) accrued when it was under the supervisor of the provisional liquidator, Paul Kabuswe has said.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
Sotorasib + panitumumab beneficial for chemorefractory metastatic CRC
For patients with chemorefractory metastatic colorectal cancer, the KRAS G12C inhibitor sotorasib in combination with the epidermal growth factor receptor inhibitor panitumumab results in longer progression-free survival than standard treatment, according to a study published online Oct. 22 in the New England Journal of Medicine. The research was published to coincide with the annual meeting of the European Society for Medical Oncology, held from Oct. 20 to 24 in Madrid.